Dr. Sara Naseri: Menstrual blood as a diagnostic tool

<p>It's estimated only one percent of medical research spending globally goes toward female-specific conditions that aren't related to cancer. But even as underfunding of women's health persists -- companies focused on women's health are innovating. Dr. Sara Naseri is working to reframe menstrual blood as a diagnostic tool rather than waste, with her company called Qvin. It received FDA clearance in January of this year for a new kind of blood test: a diagnostic menstrual pad. </p>Plus, Axios senior health care editor Adriel Bettelheim on innovations in women's health.<p>Guests: Dr. Sara Naseri, CEO and co-founder of...